Barlogie B - Search Results

1

Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells.

Bam R, Venkateshaiah SU, Khan S, Ling W, Randal SS, Li X, Zhang Q, van Rhee F, Barlogie B, Epstein J, Yaccoby S. Bam R, et al. Among authors: barlogie b. Blood Cancer J. 2014 Aug 1;4(8):e234. doi: 10.1038/bcj.2014.54. Blood Cancer J. 2014. PMID: 25083818 Free PMC article.

2

Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations.

Yaccoby S, Barlogie B, Epstein J. Yaccoby S, et al. Among authors: barlogie b. Blood. 1998 Oct 15;92(8):2908-13. Blood. 1998. PMID: 9763577 Free article.

3

Multiple myeloma--recent developments in molecular and cellular biology.

Barlogie B, Hoover R, Epstein J. Barlogie B, et al. Curr Top Microbiol Immunol. 1995;194:37-41. doi: 10.1007/978-3-642-79275-5_5. Curr Top Microbiol Immunol. 1995. PMID: 7895511 Review. No abstract available.

4

Interleukin-6 prevents dexamethasone-induced myeloma cell death.

Hardin J, MacLeod S, Grigorieva I, Chang R, Barlogie B, Xiao H, Epstein J. Hardin J, et al. Among authors: barlogie b. Blood. 1994 Nov 1;84(9):3063-70. Blood. 1994. PMID: 7949178 Free article.

5

Deletion of the retinoblastoma gene in multiple myeloma.

Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G. Dao DD, et al. Among authors: barlogie b. Leukemia. 1994 Aug;8(8):1280-4. Leukemia. 1994. PMID: 8057662

6

Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2.

Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS. Feinman R, et al. Among authors: barlogie b. Blood. 1999 May 1;93(9):3044-52. Blood. 1999. PMID: 10216101 Free article.

7

Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.

Yaccoby S, Pennisi A, Li X, Dillon SR, Zhan F, Barlogie B, Shaughnessy JD Jr. Yaccoby S, et al. Among authors: barlogie b. Leukemia. 2008 Feb;22(2):406-13. doi: 10.1038/sj.leu.2405048. Epub 2007 Nov 29. Leukemia. 2008. PMID: 18046446 Free PMC article.

8

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma.

Heuck CJ, Qu P, van Rhee F, Waheed S, Usmani SZ, Epstein J, Zhang Q, Edmondson R, Hoering A, Crowley J, Barlogie B. Heuck CJ, et al. Among authors: barlogie b. Leukemia. 2014 Dec;28(12):2410-3. doi: 10.1038/leu.2014.232. Epub 2014 Jul 31. Leukemia. 2014. PMID: 25079174 Free PMC article. No abstract available.

9

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib.

Atrash S, Tullos A, Panozzo S, Bhutani M, Van Rhee F, Barlogie B, Usmani SZ. Atrash S, et al. Among authors: barlogie b. Blood Cancer J. 2015 Jan 16;5(1):e272. doi: 10.1038/bcj.2014.93. Blood Cancer J. 2015. PMID: 25594159 Free PMC article. No abstract available.

10

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma.

Papanikolaou X, Alapat D, Rosenthal A, Stein C, Epstein J, Owens R, Yaccoby S, Johnson S, Bailey C, Heuck C, Tian E, Joiner A, van Rhee F, Khan R, Zangari M, Jethava Y, Waheed S, Davies F, Morgan G, Barlogie B. Papanikolaou X, et al. Among authors: barlogie b. Leukemia. 2015 Aug;29(8):1713-20. doi: 10.1038/leu.2015.65. Epub 2015 Mar 10. Leukemia. 2015. PMID: 25753926 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

695 results

Search Page